| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.28e-04 | 441 | 40 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | lamin binding | 6.55e-04 | 19 | 40 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 7.86e-04 | 775 | 40 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.25e-03 | 839 | 40 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.26e-03 | 840 | 40 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.26e-03 | 840 | 40 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.30e-03 | 614 | 40 | 6 | GO:0140657 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 1.27e-04 | 9 | 40 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | nuclear speck | 1.57e-04 | 431 | 40 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 2.64e-04 | 903 | 40 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | cytosolic region | 3.25e-04 | 70 | 40 | 3 | GO:0099522 | |
| GeneOntologyCellularComponent | axoneme | 6.46e-04 | 207 | 40 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.57e-04 | 208 | 40 | 4 | GO:0097014 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.04e-03 | 25 | 40 | 2 | GO:0005858 | |
| MousePheno | abnormal hippocampus neuron morphology | 5.82e-06 | 115 | 32 | 5 | MP:0009939 | |
| MousePheno | abnormal hippocampus morphology | 9.07e-05 | 331 | 32 | 6 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 1.00e-04 | 337 | 32 | 6 | MP:0000801 | |
| Domain | Pkinase_C | 6.72e-05 | 37 | 40 | 3 | IPR017892 | |
| Domain | Pkinase_C | 9.86e-05 | 42 | 40 | 3 | PF00433 | |
| Domain | AGC-kinase_C | 2.33e-04 | 56 | 40 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.33e-04 | 56 | 40 | 3 | PS51285 | |
| Domain | S_TK_X | 2.33e-04 | 56 | 40 | 3 | SM00133 | |
| Domain | AAA+_ATPase | 2.50e-04 | 144 | 40 | 4 | IPR003593 | |
| Domain | AAA | 2.50e-04 | 144 | 40 | 4 | SM00382 | |
| Domain | - | 9.29e-04 | 746 | 40 | 7 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.95e-03 | 848 | 40 | 7 | IPR027417 | |
| Domain | ARM-like | 2.59e-03 | 270 | 40 | 4 | IPR011989 | |
| Domain | ARM-type_fold | 5.82e-03 | 339 | 40 | 4 | IPR016024 | |
| Domain | C1_1 | 6.63e-03 | 57 | 40 | 2 | PF00130 | |
| Domain | Ser/Thr_kinase_AS | 6.97e-03 | 357 | 40 | 4 | IPR008271 | |
| Domain | S_TKc | 7.11e-03 | 359 | 40 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 7.32e-03 | 362 | 40 | 4 | PS00108 | |
| Domain | ZF_DAG_PE_1 | 8.29e-03 | 64 | 40 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 8.29e-03 | 64 | 40 | 2 | PS50081 | |
| Domain | C1 | 8.54e-03 | 65 | 40 | 2 | SM00109 | |
| Domain | Pkinase | 8.73e-03 | 381 | 40 | 4 | PF00069 | |
| Domain | PE/DAG-bd | 8.80e-03 | 66 | 40 | 2 | IPR002219 | |
| Domain | Olfact_rcpt | 9.71e-03 | 393 | 40 | 4 | IPR000725 | |
| Domain | - | 1.18e-02 | 222 | 40 | 3 | 1.25.10.10 | |
| Pubmed | DNAH2 ROCK2 KNTC1 HADHB LATS2 TRIP12 SYNE1 CHD5 RYR2 SEC62 STARD10 ABCB1 NOC3L | 6.04e-09 | 1442 | 41 | 13 | 35575683 | |
| Pubmed | Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. | 4.06e-06 | 3 | 41 | 2 | 24615293 | |
| Pubmed | ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. | 4.06e-06 | 3 | 41 | 2 | 24647572 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 20056007 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19666843 | ||
| Pubmed | Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. | 2.84e-05 | 7 | 41 | 2 | 31754005 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 29162624 | ||
| Pubmed | 4.35e-05 | 332 | 41 | 5 | 25693804 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 19506903 | ||
| Pubmed | Common variation contributes to the genetic architecture of social communication traits. | 6.07e-05 | 10 | 41 | 2 | 24047820 | |
| Pubmed | Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. | 7.41e-05 | 11 | 41 | 2 | 21423810 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.45e-05 | 202 | 41 | 4 | 33005030 | |
| Pubmed | 9.69e-05 | 638 | 41 | 6 | 31182584 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.06e-04 | 208 | 41 | 4 | 33230847 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 20338046 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 21301993 | ||
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 24386095 | ||
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 30093551 | ||
| Pubmed | 2.17e-04 | 251 | 41 | 4 | 27507650 | ||
| Pubmed | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. | 2.54e-04 | 20 | 41 | 2 | 19626040 | |
| Pubmed | 2.82e-04 | 777 | 41 | 6 | 35844135 | ||
| Pubmed | 3.37e-04 | 1139 | 41 | 7 | 36417873 | ||
| Pubmed | Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. | 3.38e-04 | 23 | 41 | 2 | 11086988 | |
| Pubmed | 3.88e-04 | 120 | 41 | 3 | 31298480 | ||
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 38877142 | ||
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 28720576 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 4.67e-04 | 27 | 41 | 2 | 18649358 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 5.14e-04 | 565 | 41 | 5 | 33567341 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 5.31e-04 | 569 | 41 | 5 | 30639242 | |
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 8617512 | ||
| Pubmed | 6.60e-04 | 144 | 41 | 3 | 35681168 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 6.83e-04 | 340 | 41 | 4 | 11875048 | |
| Pubmed | 6.83e-04 | 340 | 41 | 4 | 11802173 | ||
| Pubmed | 7.06e-04 | 343 | 41 | 4 | 32295537 | ||
| Pubmed | 7.29e-04 | 346 | 41 | 4 | 14611657 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 9.28e-04 | 38 | 41 | 2 | 19608861 | |
| Pubmed | 9.32e-04 | 645 | 41 | 5 | 25281560 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.00e-03 | 377 | 41 | 4 | 38117590 | |
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 30865227 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.03e-03 | 168 | 41 | 3 | 30631154 | |
| GeneFamily | Olfactory receptors, family 2 | 1.06e-02 | 113 | 25 | 2 | 149 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 7.41e-06 | 178 | 40 | 5 | M6326 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP | 8.04e-06 | 181 | 40 | 5 | M6323 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_500 | 6.00e-05 | 116 | 39 | 4 | gudmap_kidney_adult_RenCorpuscGlomer_k2_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 8.88e-05 | 405 | 39 | 6 | GSM538343_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 9.90e-05 | 255 | 39 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.05e-04 | 607 | 39 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.27e-04 | 432 | 39 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-08 | 198 | 41 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-07 | 186 | 41 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.44e-07 | 190 | 41 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.44e-07 | 190 | 41 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-07 | 196 | 41 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.84e-07 | 196 | 41 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 198 | 41 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 198 | 41 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 198 | 41 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 161 | 41 | 4 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.83e-05 | 171 | 41 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 176 | 41 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 177 | 41 | 4 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 177 | 41 | 4 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.14e-05 | 178 | 41 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 181 | 41 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 2.38e-05 | 183 | 41 | 4 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.38e-05 | 183 | 41 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 41 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-05 | 186 | 41 | 4 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 41 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.59e-05 | 187 | 41 | 4 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.65e-05 | 188 | 41 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 189 | 41 | 4 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.71e-05 | 189 | 41 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.00e-05 | 194 | 41 | 4 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-05 | 196 | 41 | 4 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-05 | 198 | 41 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 3.31e-05 | 199 | 41 | 4 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 3.31e-05 | 199 | 41 | 4 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.31e-05 | 199 | 41 | 4 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | severe-gd_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | e5a17a9f8f3be05d6abe1116607d17633df3c7ef | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.31e-05 | 199 | 41 | 4 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.53e-04 | 150 | 41 | 3 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.67e-04 | 152 | 41 | 3 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm_gut_CD8|blood / Manually curated celltypes from each tissue | 3.81e-04 | 154 | 41 | 3 | c77a02df403358361aca86c679d5c43a64ff2f7f | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.96e-04 | 156 | 41 | 3 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 4.18e-04 | 159 | 41 | 3 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-04 | 160 | 41 | 3 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-04 | 160 | 41 | 3 | 2065938e944eb99478fd8132c2c03adeaee6d447 | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 4.26e-04 | 160 | 41 | 3 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.34e-04 | 161 | 41 | 3 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-04 | 165 | 41 | 3 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.00e-04 | 169 | 41 | 3 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.00e-04 | 169 | 41 | 3 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.00e-04 | 169 | 41 | 3 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.17e-04 | 171 | 41 | 3 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.26e-04 | 172 | 41 | 3 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.26e-04 | 172 | 41 | 3 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.26e-04 | 172 | 41 | 3 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 172 | 41 | 3 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.26e-04 | 172 | 41 | 3 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.35e-04 | 173 | 41 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-04 | 173 | 41 | 3 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 5.53e-04 | 175 | 41 | 3 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 5.62e-04 | 176 | 41 | 3 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-04 | 176 | 41 | 3 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 5.91e-04 | 179 | 41 | 3 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-04 | 181 | 41 | 3 | 338c7362d258a87f1a6b1a65376f5394d4b2b4b2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-04 | 181 | 41 | 3 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 181 | 41 | 3 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-04 | 181 | 41 | 3 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.10e-04 | 181 | 41 | 3 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 181 | 41 | 3 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-04 | 183 | 41 | 3 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-04 | 183 | 41 | 3 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-04 | 184 | 41 | 3 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.40e-04 | 184 | 41 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 6.40e-04 | 184 | 41 | 3 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 6.40e-04 | 184 | 41 | 3 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-04 | 184 | 41 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 6.50e-04 | 185 | 41 | 3 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 185 | 41 | 3 | 736bf89a7a1a840ab6920060f2d98598332065a0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.50e-04 | 185 | 41 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 6.50e-04 | 185 | 41 | 3 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 6.50e-04 | 185 | 41 | 3 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 186 | 41 | 3 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 186 | 41 | 3 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 6.71e-04 | 187 | 41 | 3 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-04 | 187 | 41 | 3 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-04 | 187 | 41 | 3 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 6.71e-04 | 187 | 41 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| Drug | 13,14-dihydro-15-ketoprostaglandin E2 | 2.94e-06 | 125 | 41 | 5 | CID004307039 | |
| Disease | Malignant neoplasm of breast | PIK3R4 OR12D3 PLCB1 COLGALT2 HADHB PTEN SYNE1 NME8 CHD5 ABCB1 | 1.23e-06 | 1074 | 40 | 10 | C0006142 |
| Disease | Malignant neoplasm of kidney | 3.15e-05 | 45 | 40 | 3 | C0740457 | |
| Disease | abdominal aortic calcification measurement | 8.01e-05 | 10 | 40 | 2 | EFO_0010272 | |
| Disease | Long QT Syndrome | 9.78e-05 | 11 | 40 | 2 | C0023976 | |
| Disease | Nasopharyngeal carcinoma | 4.07e-04 | 22 | 40 | 2 | C2931822 | |
| Disease | basophil count | 4.72e-04 | 483 | 40 | 5 | EFO_0005090 | |
| Disease | fatty liver disease (implicated_via_orthology) | 8.13e-04 | 31 | 40 | 2 | DOID:9452 (implicated_via_orthology) | |
| Disease | female fertility, fertility measurement | 9.21e-04 | 33 | 40 | 2 | EFO_0006918, EFO_0006923 | |
| Disease | triacylglycerol 52:5 measurement | 1.04e-03 | 35 | 40 | 2 | EFO_0010417 | |
| Disease | Kidney Neoplasm | 1.35e-03 | 40 | 40 | 2 | C0022665 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSMSKKLMKSDKKIA | 906 | Q8IVF6 | |
| KSSGKLMLLQKMLKK | 1021 | Q8TDI0 | |
| LYLRMFKLKKDHAMK | 1166 | P51816 | |
| KLINFMKMLSQKLKS | 541 | Q7Z2Y8 | |
| DIYAMKVMKKKALLA | 121 | O14578 | |
| SRKMRKLMLDLNKAK | 176 | P55084 | |
| NTKLLAEMKMKKDLF | 46 | O95825 | |
| MKMLSGQALKDKKEL | 876 | P08183 | |
| DMMMLKKSAFKKLIK | 621 | P19113 | |
| QKMMQAGKKFKDSLL | 116 | Q6PIW4 | |
| NRLKRAKMDKSMFVK | 656 | Q9NRM7 | |
| TLRNKDMKDALKKLM | 291 | Q9Y3N9 | |
| KLLQESYKLMEMKKL | 831 | P50748 | |
| VMMALKKIFGRKLFK | 296 | Q9UGF7 | |
| KMLINFLAKSKMISL | 96 | Q8NGV6 | |
| KKNLMALKKFVMVKF | 216 | P50897 | |
| ILKYEKKLAKMCFLM | 246 | Q9H1Y3 | |
| NIMTKMDLLSKKAKK | 171 | Q9UHW5 | |
| MNSLTFKKSKDMRAK | 1381 | Q96N67 | |
| PKAFKLLKKLMRLNM | 386 | O94769 | |
| MMKQKERFAALAKFK | 281 | Q9Y6V7 | |
| FEHQFKKKLMKLMDN | 441 | Q8IYK4 | |
| MFEKLINKMLAFKKD | 2256 | Q9P225 | |
| KYTDKALMQLEKLKM | 311 | Q9Y6X3 | |
| MRMLSLKSLKKQMKK | 4256 | Q92736 | |
| NGLKMLMKRALKFKD | 466 | Q92845 | |
| LMKRALKFKDPLLMK | 471 | Q92845 | |
| EFFHKQNKMLKKDKM | 256 | P60484 | |
| MKNMLKSNFLHKKMN | 301 | Q8NGZ0 | |
| KFMTFKEKRKSLSRM | 446 | Q8WTT2 | |
| SLLKDKIFAKMEKLM | 201 | Q99983 | |
| NKSSQFLAPKAMKKM | 201 | Q9Y365 | |
| ASLNSKCKMLTMKAK | 5796 | Q8NF91 | |
| KLLALKDFMMKSNKA | 786 | Q99570 | |
| KELLNKLMLMSGKKD | 1586 | Q63HN8 | |
| DFKKMKSMKLEKTLA | 306 | Q8N427 | |
| LKKQFFHRALKVMKM | 86 | Q99442 | |
| DASKKMKNGLMFVKL | 26 | Q5TBB1 | |
| KVYAMKLLSKFEMIK | 116 | O75116 | |
| MDLMYKILVKNKKKS | 456 | Q9NQ66 | |
| LLKAKMKNMNLSKKP | 226 | Q86XD8 | |
| AKVKMKFRFLGKLMA | 1691 | Q14669 |